Entelos has secured a $6.5 million debt financing loan from Imperium Master Fund. The company plans to use about $1.5 million to pay off debt related to last year’s $8.3 million acquisition of Iconix Biosciences. It will use the remaining $5 million for various other expenses that are still to be determined, though further development of its PhysioLab simulation platform is a likely target.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.